According to the latest IMARC group report, entitled “North America Active Pharmaceutical Ingredients Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2021-2026“, the North America’s Active Pharmaceutical Ingredient Market To Reach US $ 72.7 Billion In 2020. Looking ahead, IMARC Group expects the market to grow at a CAGR of 6.2% during 2021-2026.
We regularly monitor the direct effect of COVID-19[female[feminine on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
Request a free sample report: https://www.imarcgroup.com/north-america-active-pharmaceutical-ingredients-market/requestsample
Active Pharmaceutical Ingredient (API) refers to a combination of biologically active substances used in a finished pharmaceutical product. Some of the common processes used for the production of an API include recombinant deoxyribonucleic acid (DNA), chemical synthesis, isolation, fermentation, and recovery from natural resources. API has a direct effect on the correction, modification and restoration of physiological functions of the body. As a result, it is widely used in the fields of oncology, pulmonology, nephrology, orthopedics, endocrinology and neurology.
The growth of API market in North America is driven by the increasing prevalence of various chronic diseases, such as diabetes and cancer. The introduction of several research and development (R&D) programs for the production of new drugs and the growing importance of generics further support the growth of the market. Apart from this, the sudden outbreak of coronavirus disease (COVID-19) has had a favorable impact on the market as it has prompted major players to manufacture large amounts of APIs to meet the demand for COVID drugs. -19 in the region.
Competitive Analysis and Segmentation of the North America Active Pharmaceutical Ingredients Market 2021-2026:
Competitive landscape with key players:
The competitive landscape of the North American active pharmaceutical ingredients market has been studied in the report along with the detailed profiles of the major players operating in the market.
Key market segmentation:
The report segmented the North America active pharmaceutical ingredients market on the basis of drug type, manufacturer type, synthesis type, product type and expression system, therapeutic application, and country. .
Breakdown by type of drug:
- Innovative active pharmaceutical ingredients
- Generic active pharmaceutical ingredients
Breakdown by type of manufacturer:
- Captive manufacturers
- Merchant API Manufacturers
Breakdown by type of synthesis:
- Synthetic active pharmaceutical ingredients
- Biotechnological active pharmaceutical ingredients
Breakdown by product and type of expression system:
- type of product
- Type of expression system
Rupture by therapeutic application:
- Cardiovascular and respiratory
- Central nervous system disorders
- Neurological disorders
Breakdown by country:
- United States
Explore the full report with table of contents and list of figures: https://bit.ly/3fXzFjh
Highlights of the report:
- Market performance (2015-2020)
- Market Outlook (2021-2026)
- Industry trends
- Market drivers and success factors
- The impact of COVID-19 on the global market
- Value chain analysis
- Global market structure
- Complete mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as part of the customization.
Browse related reports:
The IMARC group is a leading market research company providing management strategies and market research worldwide. We partner with clients across industries and regions to identify their most exciting opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include key business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasting and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and new processing methods are at the top of the market. business expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: + 1-631-791-1145 | Europe & Africa: + 44-753-713-2163 | Asia: + 91-120-433-0800